Building Collaborations,
Accelerating Development
At GO Therapeutics, we have one overriding criterion when we consider new partners: will this collaboration get treatments to patients faster?
Our discovery platform is generating an expansive number of validated targets on solid tumors. In addition to wholly owned programs, we are establishing collaborations with biopharmaceutical partners to expand our R&D and clinical development activities.
We invite potential partners to contact us to explore working together to bring first-in-class treatments to patients.
